← All Pfizer INC filings

Pfizer INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Receives Stock Grant
Mortimer J Buckley, a Director of Pfizer Inc, received 1,308 shares of common stock on September 25, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Receives Stock Grant
Joseph Echevarria, a Director of Pfizer Inc, received 1,613 shares of common stock on September 25, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Receives Stock Grant
Shantanu Narayen, a Director of Pfizer Inc, received 1,744 shares of common stock on September 25, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Receives Stock Grant
James Quincey, a Director of Pfizer Inc, received 1,352 shares of common stock on September 25, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Receives Stock Grant
Cyrus Taraporevala, a Director of Pfizer Inc, received 1,308 shares of common stock on September 25, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Receives Stock Grant
James C Smith, a Director of Pfizer Inc, received 1,570 shares of common stock on September 25, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 22 shares of common stock on September 15, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 21 shares of common stock on August 31, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 22 shares of common stock on August 14, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Buys Shares
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, purchased 38,000 shares of common stock on August 12, 2026 for $26.34 per share.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Executive Sells Shares
Jennifer B. Damico, SVP & Controller of Pfizer Inc, sold 3,278 shares of common stock on August 5, 2026 for $25.40 per share.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Buys Shares
Ronald E Blaylock, a Director of Pfizer Inc, purchased 39,231 shares of common stock on August 5, 2026 for $25.46 per share.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 24 shares of common stock on July 31, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 24 shares of common stock on July 15, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 84 shares of common stock on July 9, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Bourla Reports Phantom Stock Unit Acquisition
Pfizer Chairman & CEO Albert Bourla acquired 25 phantom stock units under a deferred compensation plan on June 30, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Mortimer Buckley Reports Stock Transactions
Pfizer Inc. director Mortimer J. Buckley has reported transactions involving phantom stock units, settling deferred compensation.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Joseph Echevarria Acquires Phantom Stock
Pfizer Inc. Director Joseph Echevarria acquired 1,904.076 phantom stock units on June 26, 2026, as part of a deferred compensation plan.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Narayen Acquires Phantom Stock Units
Pfizer Inc. director Shantanu Narayen acquired 2,058.46 phantom stock units, representing deferred compensation.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Acquires Phantom Stock Units
Pfizer Inc. director James C. Smith acquired 1,852.614 phantom stock units, representing deferred compensation, on June 26, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Acquires Phantom Stock Units
Pfizer Inc. director James Quincey acquired 1,595.307 phantom stock units, representing deferred compensation.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Reports Phantom Stock Unit Transaction
Pfizer Inc. director Cyrus Taraporevala reported a transaction involving phantom stock units, settled in common stock.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Bourla Acquires Phantom Stock Units
Pfizer Chairman & CEO Albert Bourla acquired 23 phantom stock units under a deferred compensation plan on June 15, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer SVP Plans Future Stock Sale Under 10b5-1 Plan
Pfizer's SVP & Controller, Jennifer B. Damico, reported a pre-planned sale of 2,000 shares of common stock scheduled for June 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Albert Bourla Acquires Phantom Stock Units
Pfizer Chairman and CEO Albert Bourla acquired 23 phantom stock units through the company's deferred compensation plan.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Bourla Acquires Phantom Stock Units
Pfizer Chairman & CEO Albert Bourla acquired 24 phantom stock units under a deferred compensation plan on May 15, 2026.
NYSE
PFE
Pfizer INC
Form 4: Pfizer CEO Bourla Reports Stock Transactions
Pfizer Chairman and CEO Albert Bourla has reported transactions involving phantom stock units acquired under a company plan.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Scott Gottlieb Acquires Phantom Stock
Pfizer Inc. director Scott Gottlieb was granted 7,686.539 phantom stock units as part of the company's deferred compensation plan for non-employee directors.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Suzanne Nora Johnson Acquires Phantom Stock
Pfizer Inc. director Suzanne Nora Johnson acquired 7,686.539 phantom stock units as part of deferred director compensation.
NYSE
PFE
Pfizer INC
Form 4: Pfizer Director Dan R. Littman Acquires Phantom Stock Units
Pfizer Inc. director Dan R. Littman was granted 7,686.539 phantom stock units as part of the company's deferred compensation plan.